Navarro Michelle S, Bachant Jeff
Department of Cell Biology and Neuroscience, University of California, Riverside, Riverside, CA 92521, USA.
Cancer Cell. 2008 Apr;13(4):293-5. doi: 10.1016/j.ccr.2008.03.011.
In vertebrate cells, the small ubiquitin-like modifier SUMO plays a poorly defined role in targeting DNA topoisomerase II (TopoII) to centromeres (CENs) during mitosis, presumably to facilitate the untangling of sister chromatids as cells transition into anaphase. A new study by Dawlaty in the April 4 issue of Cell identifies the nucleoporin RanBP2 as a novel tumor suppressor that acts as a SUMO ligase for TopoII. Analysis of this interaction reveals TopoII recruitment to CENs is likely to play an important role in preventing chromosome segregation errors that lead to cancer.
在脊椎动物细胞中,小泛素样修饰物SUMO在有丝分裂期间将DNA拓扑异构酶II(TopoII)靶向着丝粒(CENs)的过程中所起的作用尚不明确,推测是为了在细胞进入后期时促进姐妹染色单体的解缠。Dawlaty在4月4日那期《细胞》杂志上发表的一项新研究确定核孔蛋白RanBP2是一种新型肿瘤抑制因子,它作为TopoII的SUMO连接酶发挥作用。对这种相互作用的分析表明,TopoII募集到CENs可能在预防导致癌症的染色体分离错误方面发挥重要作用。